Surmodics PE Ratio 2010-2025 | SRDX
Current and historical p/e ratio for Surmodics (SRDX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Surmodics PE ratio as of June 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Surmodics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-20 | 29.00 | 0.00 | |
| 2025-03-31 | 30.53 | $-1.39 | 0.00 |
| 2024-12-31 | 39.60 | $-1.01 | 0.00 |
| 2024-09-30 | 38.78 | $-0.81 | 0.00 |
| 2024-06-30 | 42.04 | $-0.10 | 0.00 |
| 2024-03-31 | 29.34 | $0.95 | 30.88 |
| 2023-12-31 | 36.35 | $0.38 | 95.66 |
| 2023-09-30 | 32.09 | $-0.12 | 0.00 |
| 2023-06-30 | 31.31 | $-1.65 | 0.00 |
| 2023-03-31 | 22.78 | $-2.58 | 0.00 |
| 2022-12-31 | 34.12 | $-2.32 | 0.00 |
| 2022-09-30 | 30.40 | $-1.96 | 0.00 |
| 2022-06-30 | 37.23 | $-0.92 | 0.00 |
| 2022-03-31 | 45.33 | $-0.75 | 0.00 |
| 2021-12-31 | 48.15 | $0.12 | 401.25 |
| 2021-09-30 | 55.60 | $0.30 | 185.33 |
| 2021-06-30 | 54.25 | $0.10 | 542.50 |
| 2021-03-31 | 56.07 | $0.52 | 107.83 |
| 2020-12-31 | 43.52 | $0.05 | 870.40 |
| 2020-09-30 | 38.91 | $0.08 | 486.38 |
| 2020-06-30 | 43.24 | $0.56 | 77.21 |
| 2020-03-31 | 33.32 | $0.49 | 68.00 |
| 2019-12-31 | 41.43 | $0.47 | 88.15 |
| 2019-09-30 | 45.74 | $0.55 | 83.16 |
| 2019-06-30 | 43.17 | $0.16 | 269.81 |
| 2019-03-31 | 43.48 | $-0.15 | 0.00 |
| 2018-12-31 | 47.26 | $-0.13 | 0.00 |
| 2018-09-30 | 74.65 | $-0.34 | 0.00 |
| 2018-06-30 | 55.20 | $-0.18 | 0.00 |
| 2018-03-31 | 38.05 | $0.07 | 543.57 |
| 2017-12-31 | 28.00 | 0 | 0.00 |
| 2017-09-30 | 31.00 | $0.29 | 106.90 |
| 2017-06-30 | 28.15 | $0.46 | 61.20 |
| 2017-03-31 | 24.05 | $0.71 | 33.87 |
| 2016-12-31 | 25.40 | $0.73 | 34.79 |
| 2016-09-30 | 30.09 | $0.75 | 40.12 |
| 2016-06-30 | 23.48 | $0.77 | 30.49 |
| 2016-03-31 | 18.41 | $0.77 | 23.91 |
| 2015-12-31 | 20.27 | $0.94 | 21.56 |
| 2015-09-30 | 21.84 | $1.02 | 21.41 |
| 2015-06-30 | 23.42 | $0.97 | 24.14 |
| 2015-03-31 | 26.03 | $0.93 | 27.99 |
| 2014-12-31 | 22.10 | $0.88 | 25.11 |
| 2014-09-30 | 18.16 | $0.87 | 20.87 |
| 2014-06-30 | 21.42 | $0.96 | 22.31 |
| 2014-03-31 | 22.60 | $0.91 | 24.84 |
| 2013-12-31 | 24.39 | $1.01 | 24.15 |
| 2013-09-30 | 23.78 | $1.04 | 22.87 |
| 2013-06-30 | 20.01 | $0.94 | 21.29 |
| 2013-03-31 | 27.25 | $0.90 | 30.28 |
| 2012-12-31 | 22.36 | $0.72 | 31.06 |
| 2012-09-30 | 20.22 | $0.58 | 34.86 |
| 2012-06-30 | 17.30 | $-0.32 | 0.00 |
| 2012-03-31 | 15.37 | $-0.27 | 0.00 |
| 2011-12-31 | 14.66 | $-0.23 | 0.00 |
| 2011-09-30 | 9.10 | $-0.40 | 0.00 |
| 2011-06-30 | 11.10 | $-0.91 | 0.00 |
| 2011-03-31 | 12.50 | $-1.18 | 0.00 |
| 2010-12-31 | 11.87 | $-1.34 | 0.00 |
| 2010-09-30 | 11.92 | $-1.21 | 0.00 |
| 2010-06-30 | 16.41 | $0.20 | 82.05 |
| 2010-03-31 | 20.94 | $0.45 | 46.53 |
| 2009-12-31 | 22.66 | $0.71 | 31.92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.415B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.811B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |